Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ayurcann Board/Management Information 2025

May 22, 2025

46644_rns_2025-05-22_55f2f0d6-911b-4feb-a474-253b9ab850f1.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

FORM 51-102F3
MATERIAL CHANGE REPORT

Item 1: Name and Address of Company
Ayurcann Holdings Corp. (the “Company”)
Unit 6, 1080 Brock Road
Pickering, Ontario L1W 3H3

Item 2: Date of Material Change
May 15, 2025.

Item 3: News Release
A news release was disseminated on May 16, 2025, via Globe Newswire and filed on the Company’s SEDAR+ profile at www.sedarplus.ca.

Item 4: Summary of Material Change
See Item 5.1 below for a full description of the material change.

Item 5.1: Full Description of Material Change
Resignation of Director
Effective May 15, 2025, Alison Gordon resigned as a director of the Company.

Item 5.2: Disclosure for Restructuring Transactions
Not applicable.

Item 6: Reliance on subsection 7.1(2) of National Instrument 51-102 (Confidentiality)
Not applicable.

Item 7: Omitted Information
No information has been omitted on the basis that it is confidential information.

Item 8: Executive Officer
For additional information with respect to this material change, the following person may be contacted:
Ayurcann Holdings Corp.
Igal Sudman, Chief Executive Officer
(905) 492-3322
[email protected]

Item 9: Date of Report
May 22, 2025.